Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alam Sutera Realty Tbk (ASRI) vs Merck Tbk. (MERK) Price & Performance

Alam Sutera Realty TbkTrade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Alam Sutera Realty Tbk vs Merck Tbk. — how do they compare? Alam Sutera Realty Tbk trades at Rp117 (market cap 2.3T, 7.84M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Alam Sutera Realty Tbk is the larger of the two by market cap, and Alam Sutera Realty Tbk is more actively traded (7.84M versus 22.8K). Which is the better fit depends on your goals.

ASRIMERK
Market Cap
2.3T1.68T
Volume
7.84M22.8K
Lot
78.36K228
Turnover
926.45M82.9M
Average Price
118.243,636.14
Value
926.45M82.9M
Indicative Equilibrium Price
1173,520
Indicative Equilibrium Volume
3K60

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASRI
View details
MERK
View details

About Alam Sutera Realty Tbk

PT Alam Sutera Realty Tbk (the company) was established under its original name of PT Adhihutama Manunggal base on notarial deed No.15 of Mrs Erly Soehandjojo, S.H, dated on Nop 3, 1993. The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Misahardi Wilamarta, S.H., dated Sep 19, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering.

Read more on ASRI

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK